StimQ Peripheral Nerve Stimulator System (PNS) Models FR4A-SPR-BO US - Product Usage: is used for peripheral neural stimulation to provide therapeutic relief for chronic, intractable pain of peripheral nerve origin. The therapy utilizes pulsed electrical current to create an electrical energy field that acts on peripheral nerves in the limbs and torso to alter the transmission of pain signals to the brain.
Published September 9, 2020 · Recall initiated: July 15, 2020
Summary
FDA records medical device Class II recall Z-2931-2020, published September 9, 2020 and initiated July 15, 2020. Recalling firm: Stimwave Technologies Inc; Status: Ongoing; Reported quantity: 6 units; Lot: FR4A-SPR-BO-US, Serial Numbers: 210431-88, 210431-89, 210431-90, 210431-91, 210431-92, 210431-93. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The product contains a non-functional component not referenced in product labeling.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Stimwave Technologies Inc
- Distributor
- Worldwide distribution - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KY, KS, LA, MD, MO, MI, MN, MA, MS, NC, NM, ND, NV, NY, NE, NJ, OK, OH, OR, PR, PA, RI, SC, TN, TX, UT, VA, WA, WI and the countries of The Netherlands, Belgium, Slovakia, Switzerland, Germany, United Kingdom, Argentina, Italy, Spain, South Africa, Iran, Israel, and Czech Republic.
- Lot
- FR4A-SPR-BO-US, Serial Numbers: 210431-88, 210431-89, 210431-90, 210431-91, 210431-92, 210431-93;
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAStimQ Peripheral Nerve Stimulator System (PNS) Model FR4A-TRL-AO US - Product Usage: is used for peripheralSeptember 9, 2020
- FDAStimQ Peripheral Nerve Stimulator System (PNS) Models: 1. FR4A-RCV-AO US and 2. FR4A-RCV-A0 EU - ProductSeptember 9, 2020
- FDADimension Vista High Sensitivity Troponin I (TNIH) Flex reagent cartridge-IVD-In vitro diagnostic use in theSeptember 9, 2020
- FDASymbia S-Series and Symbia T-Series - Product Usage: Intended use of the device SPECT: To detect or image theSeptember 9, 2020
- FDAThe Vantage Total Ankle Tibial Insert, Fixed Bearing, Size 4, Right 10mm.September 9, 2020
- FDAParvovirus B19 IgG EIA kit Part No. V519IGUSSeptember 9, 2020
Questions about this recall
Was StimQ Peripheral Nerve Stimulator System (PNS) Models FR4A-SPR-BO US - Product Usage: is used for peripheral neural stimulation to provide therapeutic relief for chronic, intractable pain of peripheral nerve origin. The therapy utilizes pulsed electrical current to create an electrical energy field that acts on peripheral nerves in the limbs and torso to alter the transmission of pain signals to the brain. recalled?
Yes. FDA published recall Z-2931-2020 on September 9, 2020. Reported hazard: The product contains a non-functional component not referenced in product labeling.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail